5AML
Three dimensional structure of human carbonic anhydrase II in complex with 2-(But-2-yn-1-ylsulfamoyl)-4-sulfamoylbenzoic acid
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | MAX II BEAMLINE I911-3 |
Synchrotron site | MAX II |
Beamline | I911-3 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2013-11-26 |
Detector | MARRESEARCH |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 42.280, 41.620, 72.040 |
Unit cell angles | 90.00, 104.48, 90.00 |
Refinement procedure
Resolution | 69.750 - 1.360 |
R-factor | 0.12016 |
Rwork | 0.118 |
R-free | 0.16114 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4bf1 |
RMSD bond length | 0.015 |
RMSD bond angle | 1.709 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Refinement software | REFMAC (5.8.0103) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 20.000 | 1.430 |
High resolution limit [Å] | 1.360 | 1.360 |
Rmerge | 0.050 | 0.390 |
Number of reflections | 52730 | |
<I/σ(I)> | 10 | 2.4 |
Completeness [%] | 99.8 | 99.7 |
Redundancy | 2.6 | 2.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 9 | 294 | 1,54 M SODIUM CITRATE 60 MM TRIS- HCL, PH 9.0, PROTEIN 10 MG/ML 5-10 MM INHIBITOR (STOCK SOLUTION WAS 100 MM INHIBITOR DISSOLVED IN 100% DIMETHYL SULFOXIDE) VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K, TIME 2-5 DAYS |